- Associated Press - Monday, December 1, 2014

CHARLOTTESVILLE, Va. (AP) - University of Virginia researchers have received more than $21 million in grant funding to conduct a clinical trial of three seizure drugs.

The drugs are commonly used to treat a potentially deadly prolonged seizure called status epilepticus.

The university said Monday in a news release that the five-year trial’s goal is to determine which drug is best to use. Researchers also want to determine each drug’s side effects.

Forty hospitals will participate in the trial.

Dr. Jaiden Kapur with the U.Va. Department of Neurology is leading the team of researchers. They plan to evaluate up to 795 patients treated with one of the drugs.

The National Institutes of Neurological Disorders and Stroke awarded the grant.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide